Clinical Trial

Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
We will conduct a prospective, non-interventional roll-over extension of the PINNACLE study (Deciphering AMD by deep phenotyping and machine learning). This will include up to 300 intermediate AMD participants (= approximately 450 untreated intermediate AMD eyes, including both unilateral (AREDS IV) and bilateral (≥AREDS II)). As per the PINNACLE study, SUMMIT study participants will continue to be followed using OCT imaging every 4 months for a further 2-years, to specifically investigate the morphological sequence of events preceding the conversion towards late AMD. Across both studies combined, we will be able to detect the earliest focal sites of disease progression over a total 5-year follow-up.
Trial Details
NCT Number NCT06682455
Lead Sponsor University of Southampton
Collaborators: King's College London, Imperial College London, Medical University of Vienna, University of Michigan, University College, London, University Hospital, Basel, Switzerland
Conditions Age-Related Macular Degeneration
Enrollment 300 participants
Start Date 2024-06-12
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-12